NASDAQ:SSKN Strata Skin Sciences (SSKN) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsInsider TradesNews and TrendsOwnershipSEC Filings About Strata Skin Sciences Stock (NASDAQ:SSKN) Get Strata Skin Sciences alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume179,498 shsMarket Capitalization$1 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Strata Skin Sciences, Inc. is a medical technology company focused on developing and commercializing dermatology products and services. Its portfolio is designed to support the treatment of skin conditions, including psoriasis, vitiligo and other pigmentary disorders. The company’s principal products include the XTRAC excimer laser system, which delivers targeted ultraviolet light therapy, and the VTRAC excimer lamp system. These devices are used by dermatology practices to provide noninvasive phototherapy. Strata Skin Sciences also offers related services, including equipment placement, clinical support and treatment-management programs. Formerly known as MELA Sciences, the company adopted the Strata Skin Sciences name in 2015 as it shifted its focus toward dermatology technologies. It serves dermatology providers primarily in the United States and also markets its products internationally through direct sales and distribution relationships.AI Generated. May Contain Errors. Read More Receive SSKN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Strata Skin Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SSKN Stock News HeadlinesSTRATA Skin Sciences Appoints Medical Device Commercial Leader Erica Jordan as Chief Executive OfficerJuly 28, 2026 | globenewswire.comNew Peer-Reviewed Publication Confirms Unprecedented Response Rates for STRATA's Excimer Laser Combined with JAK Inhibitors in Pediatric VitiligoMay 18, 2026 | globenewswire.comTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.October 3 at 1:00 AM | Banyan Hill Publishing (Ad)STRATA Skin Sciences Confirms Nasdaq DelistingFebruary 19, 2026 | globenewswire.comSTRATA cites study supporting 308 nm laser for psoriasisFebruary 18, 2026 | msn.comJohns Hopkins Dermatology Expands Advanced Care for Inflammatory and Autoimmune Skin Conditions with Addition of XTRAC® Excimer LaserFebruary 18, 2026 | globenewswire.comSTRATA Skin Sciences Highlights Meta-Analysis Confirming Clinical Efficacy of 308 nm Excimer Laser for Plaque PsoriasisFebruary 17, 2026 | globenewswire.comSTRATA Skin Sciences stock plunges after Nasdaq delisting noticeFebruary 12, 2026 | in.investing.comSee More Headlines SSKN Stock Analysis - Frequently Asked Questions How have SSKN shares performed this year? Strata Skin Sciences' stock was trading at $1.26 on January 1st, 2026. Since then, SSKN shares have decreased by 100.0% and is now trading at $0.0001. How were Strata Skin Sciences' earnings last quarter? Strata Skin Sciences, Inc. (NASDAQ:SSKN) released its quarterly earnings data on Thursday, November, 13th. The medical device company reported ($0.36) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.24) by $0.12. The medical device company earned $6.93 million during the quarter, compared to analyst estimates of $7.72 million. Strata Skin Sciences had a negative trailing twelve-month return on equity of 476.73% and a negative net margin of 35.64%. Read the conference call transcript. When did Strata Skin Sciences' stock split? Strata Skin Sciences's stock reverse split on Friday, June 7th 2024.The 1-10 reverse split was announced on Friday, June 7th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, June 7th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of Strata Skin Sciences? Shares of SSKN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Strata Skin Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Strata Skin Sciences investors own include Amarin (AMRN), AbbVie (ABBV), OPKO Health (OPK), AT&T (T), Agile Therapeutics (AGRX), Advanced Micro Devices (AMD) and Avino Silver & Gold Mines (ASM). Company Calendar Last Earnings11/13/2025Today10/03/2026Next Earnings (Estimated)11/17/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (8m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 SSKN's financial health is in the Red zone, according to TradeSmith. SSKN has been in this zone for over 8 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:SSKN CIK1051514 Webwww.strataskinsciences.com Phone(215) 619-3200Fax215-619-3208Employees114Year Founded1989Profitability EPS (Trailing Twelve Months)($1.41) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$10.09 million Net Margins-35.64% Pretax Margin-36.34% Return on Equity-476.73% Return on Assets-33.49% Debt Debt-to-Equity Ratio10.22 Current Ratio0.95 Quick Ratio0.75 Sales & Book Value Annual Sales$30.98 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$1.19 per share Price / BookN/AMiscellaneous Outstanding Shares5,888,000Free Float3,479,000Market Cap$1 thousand OptionableNot Optionable Beta0.03 Social Links Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NASDAQ:SSKN) was last updated on 10/3/2026 by MarketBeat.com Staff. From Our PartnersThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Strata Skin Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Strata Skin Sciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
